Investigating the role of enolase in prostate cancer disparities among men of different ancestries
Role and Theranostics Potential of Enolase in Prostate Cancer Health Disparities
This study is looking into why men of African descent are more likely to get prostate cancer than men of European descent, by exploring how their immune systems react to a certain enzyme, with the hope of finding new ways to treat prostate cancer.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Loma Linda University NIH-funded |
| Lab location | 1 site (Loma Linda, UNITED STATES) |
| Project ID | NIH-10819531 on NIH RePORTER |
What this research studies
This research focuses on understanding why men of African ancestry experience higher rates of prostate cancer compared to men of European ancestry. It examines the differences in immune responses to a specific enzyme called enolase, which may play a role in cancer progression. By analyzing how these immune responses differ between the two groups, the research aims to identify new therapeutic targets that could lead to better treatment options for prostate cancer. The study will utilize advanced techniques to explore the molecular mechanisms involved and develop potential new therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with prostate cancer, especially those of African ancestry.
Not a fit: Patients who do not have prostate cancer or those of European ancestry may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that improve outcomes for men with prostate cancer, particularly those of African ancestry.
How similar studies have performed: Previous research has shown promising results in understanding cancer disparities and developing targeted therapies, suggesting that this approach could yield valuable insights.
Where this research is happening
Loma Linda, UNITED STATES
- Loma Linda University — Loma Linda, United States (Active)
Researchers
- Principal investigator: Casiano, Carlos a. — Loma Linda University
- Study coordinator: Casiano, Carlos a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.